SCHEMBL9951059

SCHEMBL9951059

O=C(c1cnc(-c2ccc(C(F)(F)F)cc2)nc1)C1CCCCC1

nearest known ligand 0.47

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
POLB P06746 3/20 0.47
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
PKM P14618 1/20 0.47
BLM P54132 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
KDM4E B2RXH2 1/20 0.44
KDM2B Q8NHM5 2/20 0.43
HSD11B1 P28845 1/20 0.43
MGLL Q99685 1/20 0.42
RAB9A P51151 1/20 0.41
LMNA P02545 1/20 0.41
TRPV1 Q8NER1 1/20 0.40
HDAC4 P56524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26081057 0.82 HSD11B1 (0.58) MAPTPOLBMEN1ALDH1A1KMT2A
SCHEMBL1855141 0.80 HSD11B1 (0.60) MAPTPOLBMEN1ALDH1A1KMT2A
SCHEMBL12613371 0.77 SRD5A2 (0.52) KMT2AHDAC4
SCHEMBL19650840 0.77 HSD11B1 (0.60) MAPTPOLBMEN1ALDH1A1KMT2A
SCHEMBL27642540 0.76 SRD5A2 (0.55) KDM2BHDAC4
SCHEMBL10200042 0.74 TRPV3 (0.47) MAPTMEN1KMT2ALMNATRPV1
SCHEMBL4023293 0.73 HSD11B1 (0.63) MAPTPOLBTDP1KDM2BHSD11B1
SCHEMBL9951087 0.72 TRPV3 (0.45) MAPTMEN1KMT2ATRPV1HDAC4
SCHEMBL10199934 0.71 TRPV3 (0.44) MAPTMEN1KMT2ALMNATRPV1
SCHEMBL2273492 0.71 LMNA (0.53) MAPTKDM4ELMNAHDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150266861-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-09-24 US disclosed
US-20150266861-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-09-24 US disclosed
US-20150266861-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-09-24 US disclosed
US-9056834-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-06-16 US disclosed
US-9056834-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-06-16 US disclosed
US-9056834-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-06-16 US disclosed
US-20150094338-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-04-02 US disclosed
US-20150094338-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-04-02 US disclosed
US-20150094338-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2015-04-02 US disclosed
US-8933104-B2 Glucagon receptor modulators PFIZER INC. (US) 2015-01-13 US disclosed
US-8809342-B2 Glucagon receptor modulators PFIZER INC. (US) 2014-08-19 US disclosed
US-8809342-B2 Glucagon receptor modulators PFIZER INC. (US) 2014-08-19 US disclosed
US-8809342-B2 Glucagon receptor modulators PFIZER INC. (US) 2014-08-19 US disclosed
EP-2655331-A1 GLUCAGON RECEPTOR MODULATORS Pfizer Inc (US) 2013-10-30 EP disclosed
CN-103261165-A Glucagon receptor modulators PFIZER 2013-08-21 CN disclosed
US-20120165343-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2012-06-28 US disclosed
US-20120165343-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2012-06-28 US disclosed
US-20120165343-A1 Glucagon Receptor Modulators PFIZER INC. (US) 2012-06-28 US disclosed
WO-2012085745-A1 GLUCAGON RECEPTOR MODULATORS PFIZER INC. (US) 2012-06-28 WO disclosed
WO-2012085745-A1 GLUCAGON RECEPTOR MODULATORS PFIZER INC. (US) 2012-06-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150094338-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAPT 4254/4885POLB 4739/4885MEN1 741/4885
US-20120165343-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAPT 4254/4885POLB 4739/4885MEN1 741/4885
US-20150266861-A1 Glucagon Receptor Modulators GLP1R, GCGR, GPR119 MAPT 4254/4885POLB 4739/4885MEN1 741/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.